Compound Detail

CHEMBL4566608

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CC1CCN(C2CCN(S(=O)(=O)c3cccc(Br)c3)CC2)CC1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4566608
Phase	Preclinical
Structure Type	MOL
InChI Key	FGLVIJVCDJTAPG-UHFFFAOYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

401.4

MW (Da)

3.33

ALogP

HBA

HBD

40.6

PSA (Å²)

0.78

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 3 meas. best 8.92

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
HT-29 CHEMBL384	IC50	8.92	8.92	1.2	1
DLD-1 CHEMBL614285	IC50	8.49	8.49	3.2	1
Unchecked CHEMBL612545	IC50	8.16	8.16	6.9	1

Parameter	Value	Units	Species
T1/2	0.2167	hr	Mus musculus

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
HT-29	IC50	=	1.2	nM	8.92	Antiproliferative activity against human HT-29 cells after 72 hrs by Celltiter-G...	31070915
DLD-1	IC50	=	3.2	nM	8.49	Antiproliferative activity against human DLD1 cells after 72 hrs by Celltiter-Gl...	31070915
Unchecked	IC50	=	6.9	nM	8.16	Antiproliferative activity against human CTRPA cells harboring APC A1309 mutant ...	31070915

PubMed	DOI	Target Context	# Activities
31070915	10.1021/acs.jmedchem.9b00532	Unchecked	2
31070915	10.1021/acs.jmedchem.9b00532	DLD-1	1
31070915	10.1021/acs.jmedchem.9b00532	HCT-116	1
31070915	10.1021/acs.jmedchem.9b00532	ADMET	1
31070915	10.1021/acs.jmedchem.9b00532	HT-29	1

Data from ChEMBL 36 via Core Engine